Latest REPH reports update at 2024-03-22: 202320222021
Recro Pharma logo

Recro Pharma REPH

$ 1.4 -4.76%

Country

usaUSA

IPO year

2014

Industry

Drug manufacturers

Stock Exchange

NASDAQ GLOBAL

CEO

Ms. Geraldine Henwood

Employees in the company

213

Shares

95.2 M

Market Cap[1]

$ 65.3 M

EBITDA (LTM)

$ -2.62 M

P/E (LTM)

-6.67

P/S (LTM)

0.74

EPS (LTM)

-0.21

Other stocks of industry "Drug manufacturers"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.